These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 22988250)
1. Mechanisms for kinase-mediated dimerization of the epidermal growth factor receptor. Lu C; Mi LZ; Schürpf T; Walz T; Springer TA J Biol Chem; 2012 Nov; 287(45):38244-53. PubMed ID: 22988250 [TBL] [Abstract][Full Text] [Related]
2. Simultaneous visualization of the extracellular and cytoplasmic domains of the epidermal growth factor receptor. Mi LZ; Lu C; Li Z; Nishida N; Walz T; Springer TA Nat Struct Mol Biol; 2011 Aug; 18(9):984-9. PubMed ID: 21822280 [TBL] [Abstract][Full Text] [Related]
3. Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor. Lu C; Mi LZ; Grey MJ; Zhu J; Graef E; Yokoyama S; Springer TA Mol Cell Biol; 2010 Nov; 30(22):5432-43. PubMed ID: 20837704 [TBL] [Abstract][Full Text] [Related]
4. Kinase-mediated quasi-dimers of EGFR. Bublil EM; Pines G; Patel G; Fruhwirth G; Ng T; Yarden Y FASEB J; 2010 Dec; 24(12):4744-55. PubMed ID: 20682838 [TBL] [Abstract][Full Text] [Related]
5. Functional and structural stability of the epidermal growth factor receptor in detergent micelles and phospholipid nanodiscs. Mi LZ; Grey MJ; Nishida N; Walz T; Lu C; Springer TA Biochemistry; 2008 Sep; 47(39):10314-23. PubMed ID: 18771282 [TBL] [Abstract][Full Text] [Related]
6. Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site. Arteaga CL; Ramsey TT; Shawver LK; Guyer CA J Biol Chem; 1997 Sep; 272(37):23247-54. PubMed ID: 9287333 [TBL] [Abstract][Full Text] [Related]
7. Gefitinib induces epidermal growth factor receptor dimers which alters the interaction characteristics with ¹²⁵I-EGF. Björkelund H; Gedda L; Barta P; Malmqvist M; Andersson K PLoS One; 2011; 6(9):e24739. PubMed ID: 21931838 [TBL] [Abstract][Full Text] [Related]
8. Effect of phosphorylation on EGFR dimer stability probed by single-molecule dynamics and FRET/FLIM. Coban O; Zanetti-Dominguez LC; Matthews DR; Rolfe DJ; Weitsman G; Barber PR; Barbeau J; Devauges V; Kampmeier F; Winn M; Vojnovic B; Parker PJ; Lidke KA; Lidke DS; Ameer-Beg SM; Martin-Fernandez ML; Ng T Biophys J; 2015 Mar; 108(5):1013-26. PubMed ID: 25762314 [TBL] [Abstract][Full Text] [Related]
9. Significant increase in hEGF uptake is correlated with formation of EGFR dimers induced by the EGFR tyrosine kinase inhibitor gefitinib. He P; Li G Cancer Chemother Pharmacol; 2013 Aug; 72(2):341-8. PubMed ID: 23748900 [TBL] [Abstract][Full Text] [Related]
10. The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant. Brown PM; Debanne MT; Grothe S; Bergsma D; Caron M; Kay C; O'Connor-McCourt MD Eur J Biochem; 1994 Oct; 225(1):223-33. PubMed ID: 7925442 [TBL] [Abstract][Full Text] [Related]
11. Architecture and membrane interactions of the EGF receptor. Arkhipov A; Shan Y; Das R; Endres NF; Eastwood MP; Wemmer DE; Kuriyan J; Shaw DE Cell; 2013 Jan; 152(3):557-69. PubMed ID: 23374350 [TBL] [Abstract][Full Text] [Related]
12. Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain. Park JH; Liu Y; Lemmon MA; Radhakrishnan R Biochem J; 2012 Dec; 448(3):417-23. PubMed ID: 23101586 [TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Ogiso H; Ishitani R; Nureki O; Fukai S; Yamanaka M; Kim JH; Saito K; Sakamoto A; Inoue M; Shirouzu M; Yokoyama S Cell; 2002 Sep; 110(6):775-87. PubMed ID: 12297050 [TBL] [Abstract][Full Text] [Related]
14. Gefitinib targets EGFR dimerization and ERK1/2 phosphorylation to inhibit pleural mesothelioma cell proliferation. Favoni RE; Pattarozzi A; Lo Casto M; Barbieri F; Gatti M; Paleari L; Bajetto A; Porcile C; Gaudino G; Mutti L; Corte G; Florio T Curr Cancer Drug Targets; 2010 Mar; 10(2):176-91. PubMed ID: 20088784 [TBL] [Abstract][Full Text] [Related]
15. Allosteric modulation by protein kinase Cε leads to modified responses of EGF receptor towards tyrosine kinase inhibitors. Weisheit S; Liebmann C Cell Signal; 2012 Feb; 24(2):422-434. PubMed ID: 21964064 [TBL] [Abstract][Full Text] [Related]
16. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. Ferguson KM; Berger MB; Mendrola JM; Cho HS; Leahy DJ; Lemmon MA Mol Cell; 2003 Feb; 11(2):507-17. PubMed ID: 12620237 [TBL] [Abstract][Full Text] [Related]
17. Control of epidermal growth factor receptor endocytosis by receptor dimerization, rather than receptor kinase activation. Wang Q; Villeneuve G; Wang Z EMBO Rep; 2005 Oct; 6(10):942-8. PubMed ID: 16113650 [TBL] [Abstract][Full Text] [Related]
18. CR1/CR2 interactions modulate the functions of the cell surface epidermal growth factor receptor. Walker F; Orchard SG; Jorissen RN; Hall NE; Zhang HH; Hoyne PA; Adams TE; Johns TG; Ward C; Garrett TP; Zhu HJ; Nerrie M; Scott AM; Nice EC; Burgess AW J Biol Chem; 2004 May; 279(21):22387-98. PubMed ID: 15016810 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface. Zhang X; Pickin KA; Bose R; Jura N; Cole PA; Kuriyan J Nature; 2007 Nov; 450(7170):741-4. PubMed ID: 18046415 [TBL] [Abstract][Full Text] [Related]
20. Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors. Jia Y; Yun CH; Park E; Ercan D; Manuia M; Juarez J; Xu C; Rhee K; Chen T; Zhang H; Palakurthi S; Jang J; Lelais G; DiDonato M; Bursulaya B; Michellys PY; Epple R; Marsilje TH; McNeill M; Lu W; Harris J; Bender S; Wong KK; Jänne PA; Eck MJ Nature; 2016 Jun; 534(7605):129-32. PubMed ID: 27251290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]